COVID-19 và thuốc chống động kinh: một phương pháp hướng dẫn thực hành khi nirmatrelvir/ritonavir được đồng kê đơn

Chiu MN, Bhardwaj M, Sah SP (2022) Safety profile of COVID-19 drugs in a real clinical setting. Eur J Clin Pharmacol 78(5):733–753. https://doi.org/10.1007/s00228-021-03270-2 Noyman I, Ekstein D, Fahoum F, Herskovitz M, Linder I, Ben Zeev B, Eyal S (2022) Using nirmatrelvir/ritonavir in patients with epilepsy: an update from the Israeli chapter of the International League Against Epilepsy. Epilepsia. https://doi.org/10.1111/epi.17212 US Food and Drug Administration (FDA). Fact sheet for healthcare providers: emergency use authorization for Paxlovid (nirmatrelvir and ritonavir). https://www.fda.gov/media/155050/download. Published December 22, 2021. Accessed 12 Mar 2022 Wang Z, Yang L (2022) In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery. J Med Virol 94(5):1766–1767. https://doi.org/10.1002/jmv.27540 Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH, Quality Standards Subcommittee of the American Academy Of N, Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against E (2012) Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia 53(1):207–214. https://doi.org/10.1111/j.1528-1167.2011.03335.x Lexicomp Online, Drug Interactions Online. Waltham, MA: UpToDate. https://online.lexi.com. Accessed 7 Mar 2022 Lİverpool Drug Interactions Group. Interactions with COVID-19 therapies. Available from: https://www.covid19-druginteractions.org/. Accessed 14 Mar 2022 Kheshti R, Aalipour M, Namazi S (2016) A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract 5(4):257–263. https://doi.org/10.4103/2279-042X.192461 Truven Health Analytics Micromedex® Solutions Drug Interactions [Internet]. https://www.micromedexsolutions.com/micromedex2/librarian/CS/93E9AD/PFActionId/pf.HomePage. Accessed 12 Mar 2022 Medscape Drug Interaction Checker [Internet]. https://reference.medscape.com/drug-interactionchecker. Accessed 14 Mar 2022 International Transporter C, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9(3):215–236. https://doi.org/10.1038/nrd3028 Britz H, Hanke N, Volz AK, Spigset O, Schwab M, Eissing T, Wendl T, Frechen S, Lehr T (2019) Physiologically-based pharmacokinetic models for CYP1A2 drug-drug interaction prediction: a modeling network of fluvoxamine, theophylline, caffeine, rifampicin, and midazolam. CPT Pharmacometrics Syst Pharmacol 8(5):296–307. https://doi.org/10.1002/psp4.12397 DDI-Predictor (2021) Quantitative prediction of drug drug interactions—DDI-Predictor academic version. https://www.ddi-predictor.org/. Accessed 14 Mar 2022 Moreau F, Simon N, Walther J, Dambrine M, Kosmalski G, Genay S, Perez M, Lecoutre D, Belaiche S, Rousseliere C, Tod M, Decaudin B, Odou P (2022) Does DDI-Predictor help pharmacists to detect drug-drug interactions and resolve medication issues more effectively? Metabolites 11(3). https://doi.org/10.3390/metabo11030173 McDonald EG, Lee TC (2022) Nirmatrelvir-ritonavir for COVID-19. CMAJ 194(6):E218. https://doi.org/10.1503/cmaj.220081 US Food and Drug Administration. Fact sheet for healthcare providers: emergency use authorization for Paxlovid. https://www.uptodate.com/contents/antiseizure-medications-mechanism-of-action-pharmacology-and-adverse-effects. Accessed 18 Mar 2022 Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back D, Khoo S (2022) Prescribing nirmatrelvir-ritonavir: how to recognize and manage drug-drug interactions. Ann Intern Med. https://doi.org/10.7326/M22-0281 Paxlovid (nirmatrelvir/ritonavir) [Emergency use authorization fact sheet for healthcare providers]. New York, NY: Pfizer Inc.; December 2021 Holford N, Ma GD, Metz D (2022) TDM is dead. Long live TCI! Brit J Clin Pharmaco 88(4):1406–1413. https://doi.org/10.1111/bcp.14434 Scheffer IE (2005) The role of genetics and ethnicity in epilepsy management. Acta Neurol Scand Suppl 181:47–51. https://doi.org/10.1111/j.1600-0404.2005.00509.x Johnson AB, Sadiq NM. Pentobarbital. [Updated 2022 Feb 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545288/. Accessed 18 Mar 2022 Sheehan NL, Brouillette MJ, Delisle MS, Allan J (2006) Possible interaction between lopinavir/ritonavir and valproic acid exacerbates bipolar disorder. Ann Pharmacother 40(1):147–150. https://doi.org/10.1345/aph.1G418 Jain S, Potschka H, Chandra PP, Tripathi M, Vohora D (2021) Management of COVID-19 in patients with seizures: mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. Epilepsy Res 174:106675. https://doi.org/10.1016/j.eplepsyres.2021.106675